Cytokinetics Inc (CYTK)
48.43
-0.76
(-1.55%)
USD |
NASDAQ |
Jan 07, 15:50
Cytokinetics SG&A Expense (Quarterly): 56.65M for Sept. 30, 2024
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Insmed Inc | 118.93M |
| Rezolute Inc | 4.187M |
| Ocugen Inc | 6.28M |
| Scholar Rock Holding Corp | 16.06M |
| Mirum Pharmaceuticals Inc | 50.54M |